Interferon may reduce minimal residual disease of acute promyelocytic leukemia

Leukemia. 2000 Jun;14(6):1153. doi: 10.1038/sj.leu.2401472.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cytarabine / administration & dosage
  • Daunorubicin / administration & dosage
  • Female
  • Humans
  • Idarubicin / administration & dosage
  • Interferons / therapeutic use*
  • Leukemia, Promyelocytic, Acute / drug therapy*
  • Neoplasm, Residual / drug therapy*
  • Recurrence
  • Remission Induction
  • Tretinoin / administration & dosage

Substances

  • Cytarabine
  • Tretinoin
  • Interferons
  • Idarubicin
  • Daunorubicin

Supplementary concepts

  • AIDA protocol